The world of pharma has experienced its fair share of trials and tribulations over the past few years. Patient access, staffing shortages, and cutting-edge research all contribute to furthering new opportunities and overcoming industry-wide challenges. Amidst the changing landscape, where are we headed?

We sit down with Rheannin Nelson, Clinician Manager at ProPharma, a research consulting organization that’s helped pharmaceutical companies conduct clinical trials since 2001, to discuss a new opportunity: decentralized clinical trials, what they are, and their potential impact on the industry for both patients and staff.